Google TrendNOVIG (2000+) — Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Prolonged GLP-1 Exposure" (30 stories)

Top Headline Story

Prolonged GLP-1 Exposure Remodels Gene Expression in the Pancreas by Flipping a Molecular Switch
Lead StoryThe Scientistgeneral
Aug 16

Prolonged GLP-1 Exposure Remodels Gene Expression in the Pancreas by Flipping a Molecular Switch

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOZW5xakVsR1ZldjVXRkNnTHBid0F1akJSVnZTT1oxdmZyeEc0dHk1YlhOcGRoWlRzejgtMXF6VTZoTkpIVVJBY29pR2lJXzhaRXlYQXFxN05jYVFxR3ZLRzNFbjY2cFp1d1ZvNGVJUGNwS3o3ZTRyakh4NzB2eFZodnR0RVNES0JoeVBWQ1JmUTZ3S3VUOWNHTkg4WGN0cHg5SzlaYjBqdXVkRHNHaG9HM1lhY0hyemg2R21iazFJLXl0UDBmWVdKYU5OQW0?oc=5" target="_blank">Prolonged GLP-1 Exposure Remodels Gene Expression in the Pancreas by Flipping a Molecular Switch</a>  <font color="#6f6f6f">The Scientist</font>

Real-time search volume
2000+23m ago

novig

Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits

500+23m ago

boise state vs fresno state

Boise State gets big health boost, but injury concerns remain vs. Fresno State

500+23m ago

sounders

NEvsSEA Starting XI: Dejan Joveljić and Yeimar return to starting lineup, Sebastian Gomez gets the nod

200+23m ago

pedro pascal

Pedro Pascal in ‘Behemoth!’: The Oscar-Worthy Role That He (and Latinos) Have Been Waiting For

Search Results for "Prolonged GLP-1 Exposure"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
How do GLP-1 agonists affect gene expression?
Salk Institutegeneral

How do GLP-1 agonists affect gene expression?

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPMFQwMTBGSkdoSkFyNWZZWVFEbnZvODZaV2RzS2lRdzdKQ0tqVm5hbWd5SGFCeEI0ZkVHdE5ZVWh5MTNqb3lmMmF3cFRsSnBkU0hIMUZDRm5BM3paMzc0aEFqQjdvd0NULUVXTHhRMk91WTV2M0JsczF1SXd1TU9iNlVTM043QQ?oc=5" target="_blank">How do GLP-1 agonists affect gene expression?</a>  <font color="#6f6f6f">Salk Institute</font>

Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy
Naturegeneral

Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90Tm0xMXVTMGUtN2xNbzJyUXF0dkZiYjA0Ql9vSndkVmp1a09nM3F4T3lJRFU1RHBhb3ZGal9Ca1Y1NGRSUUVBQ1ZPYzFaUFI1R2hFZEtiZmlza01EZDNJ?oc=5" target="_blank">Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy</a>  <font color="#6f6f6f">Nature</font>

GLP-1 Drugs Modulate Gene Expression via MED14 Phosphorylation
Genetic Engineering and Biotechnology Newsgeneral

GLP-1 Drugs Modulate Gene Expression via MED14 Phosphorylation

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQcjlBb3Y1RWhiVTRHTy1TYjY1SUVjMERzaWhOTDFOTG94TkRPcGRRa3BnMnRxblpVRWVlR1VoOGpQUDZBRklhZlBWblNpTTV4c2NEcHRSZWZNUmEyOTJHcVpDRWFBUmdhMjA1WXZ5Mkd0X0FQOWtna2V0b0xrZVZmZ0h3dzY1QUtyb2FWX25jSmRRNWVPc254YlJNZEVlbnN1eklxX1dKWmVqV1FkOW9mOW1B?oc=5" target="_blank">GLP-1 Drugs Modulate Gene Expression via MED14 Phosphorylation</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

Med14 phosphorylation shapes genomic response to GLP-1 agonists
PNASgeneral

Med14 phosphorylation shapes genomic response to GLP-1 agonists

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5XYWVORGhxWk5FQklRUk5uTU01NHNDeVdMSGJaWE9WNlRpNldleEtlSUdvbGVjWVo4ekZBZEFGZzI0RDRCUDF2TTNTcTU0Vlg3SUpxSmJjMTFpTENx?oc=5" target="_blank">Med14 phosphorylation shapes genomic response to GLP-1 agonists</a>  <font color="#6f6f6f">PNAS</font>

Long-Term GLP-1 Safety: GI Risks After 3 Years
Diabetes In Controlgeneral

Long-Term GLP-1 Safety: GI Risks After 3 Years

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1vRFAwVV85aUEyZ1pOTEYtLUM4bjlXY0k0ajYxMkFQbDJUTkpjZEZLSnlUTVRUbmhXUjJTQ1hsd1M2SnhEOTlpSHVCZDlSeHU5OXRxUDhEci1MT3hyd2NEb1QzTUM1Tlc2?oc=5" target="_blank">Long-Term GLP-1 Safety: GI Risks After 3 Years</a>  <font color="#6f6f6f">Diabetes In Control</font>

Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes
PR Newswirescience

Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes

<a href="https://news.google.com/rss/articles/CBMikAJBVV95cUxOUUpPa3NudXRtVEs0ZXZXUnZGQWhjWUlLNkFWcG9RYzg0cTFRR2ZfUGV0V3lJMlRlRDRMYnV5Z3V6OVhxaVpRNnFvQW1rU2twMGZsZURFSF9aX1h0UG5hVmYzWmctT0FrRFc2UnJybHVBTDJEdmhweG0xQkZQU0ZoSHhLUGlBTlNZQm5OeC1yZEk5UERhUFVYdm5FY2pxbXVwVjNNVWlTTk9LNHVRd3FkWUJjdGYtaEZGMS1UcmoxV1A0U21qTnpibGdJaVJmMWsya3FPZzFGNjNtcnAzeHpGaWZHbWVBcTZjRE5uazRJbW16dU5NVzlkcTBEMVM1VlBWdUplcjljbkhGcmhSYmNjXw?oc=5" target="_blank">Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes</a>  <font color="#6f6f6f">PR Newswire</font>

Bone health: GLP-1s may increase osteoporosis risk
MedicalNewsTodayscience

Bone health: GLP-1s may increase osteoporosis risk

<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTFBMTWc3OVduaDhGMUhCZ0hIbmhRWHpPVWJkTnF4bGlQaWlfQm9jbGFfM2VlMklaUFVUMXRzdXVLQ1lodHkzRXlVM2s4VGZwaW5ERDJRSFdEaVRiTDlNazNqMGRVbGdqbVc3aVo5VmZSN05KR0M5S1J1WGpiZVlXUQ?oc=5" target="_blank">Bone health: GLP-1s may increase osteoporosis risk</a>  <font color="#6f6f6f">MedicalNewsToday</font>

GLP-1 Thyroid Cancer Human Data: What Clinicians Should Know
Diabetes In Controlgeneral

GLP-1 Thyroid Cancer Human Data: What Clinicians Should Know

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1IcVZ1V0JXbmk4Nks3eUtrQzU2NG84ZU9mT3I0YUR4X3hUem1NYW9PMGpJdnJoR09jTjVxZFUtWURpUVBPbnhKNFFGWWYzREtyekhfcEFaenBLTGMxWnZ5bjZWRzVYNDRHVEZIUl9tbjBVLVk?oc=5" target="_blank">GLP-1 Thyroid Cancer Human Data: What Clinicians Should Know</a>  <font color="#6f6f6f">Diabetes In Control</font>

‘Mormon Wives’ Star Mikayla Matthews Says She’s ‘Barely Surviving’ Due to Chronic Illness
The Daily Beastgeneral

‘Mormon Wives’ Star Mikayla Matthews Says She’s ‘Barely Surviving’ Due to Chronic Illness

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPTURMcDJhTEZ4UjhmTGZTS2NGeFJTZnV2NjJEOHo4dzdhTFlXbnZtRzBBMHBNLXozTmlLRGY4d09FY2k4X1BuUEN2TGt3dGVlVG5DXzdGZkNseW5jVTdsOWZIOXB5UC1DeU9IU2w0ZlQtVlJhaUxFLVVkSXI2bnpzcVFrTnZhV1Q3VGJrTmJGQ3BYeWdiMzZpWmJtMFlVY3RBSzZRcWF3QVpwRzVOTUJLX3hHcWE?oc=5" target="_blank">‘Mormon Wives’ Star Mikayla Matthews Says She’s ‘Barely Surviving’ Due to Chronic Illness</a>  <font color="#6f6f6f">The Daily Beast</font>

GLP-1 Gastric Motility Adaptation: Does the Stomach Adjust?
Diabetes In Controlgeneral

GLP-1 Gastric Motility Adaptation: Does the Stomach Adjust?

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9Wc2RTUzJDa0VabnFKMHBBVFZzSkotSkxUc3hMZklLUzlibEQxRVFrZW4yLWtNeVNqeUlSR1RWazAtd3V5MlFDeE4yeU56Mk95NjVYNkFWN3U1UUxPOWhYWTZOSlFVQ1E2bEk2c0hkZHhRTW93NFE?oc=5" target="_blank">GLP-1 Gastric Motility Adaptation: Does the Stomach Adjust?</a>  <font color="#6f6f6f">Diabetes In Control</font>

Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy
Naturegeneral

Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TRFhqOTg4eVhaYVdnejkwTVpaRkl1QTJjd0dRMHN3R29ST2dzdkdjNG9BdU1xdDRPMXotc1l5QW03RHVaVE0takhCQmJEMnJfem1pcnlVSWR3S0Z1TjI0?oc=5" target="_blank">Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy</a>  <font color="#6f6f6f">Nature</font>

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy
Naturegeneral

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBrblBnd2pwWm5YN2RsN2h1ZkkwU3d1b25oT1NwY3k1ajBsVGxkNlZyWmwwTC02NFVlNzQyR013N29EaTBMUjRRWW54aHpjdUVwbFNuQ0RheVdXaEhJbEdn?oc=5" target="_blank">Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy | Scientific Reports
Naturegeneral

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9iUXRfVGdhT2VUa3Rkc1FONW5JdkZoWDREckU2bE1PQmVuNW5Tb0xDN3BsRVF2a1JoZHVya01TRWNCSDhVQW42TDIzQ0JMd18tTGI4NVd0NVdWTlYzbUhz?oc=5" target="_blank">The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression
Naturegeneral

Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAycC15MWljMnlCNTB5Wjd2eWhpUGVQWGJFcE1TejVNUndFbXo5VU9JZ01Fc2VSYktwb3JVYzl2cUdoMzMxMkhFVEtVWG82c2p5enotMlgwTHNmcE9LTGVN?oc=5" target="_blank">Prolonged glucagon exposure rewires lipid oxidation and drives diabetic kidney disease progression</a>  <font color="#6f6f6f">Nature</font>

Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end | Communications Biology
Natureworld

Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end | Communications Biology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HREpfM2tkQmZSU2FveW1WZUJKS1B1X1E4NllOSVNTQTREOHR1V203bDFEdDN0VVZQUG5NSEQxX1FqdDZ2OGFkNWhPMVRDejhzdGZ2R2Y3QUloWUNacV9N?oc=5" target="_blank">Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end | Communications Biology</a>  <font color="#6f6f6f">Nature</font>

Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial
Naturegeneral

Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE04dng2MzlReXQtUXpoTnBqeHZEUkpSSE1VaGRvN3ZzMXZtTFF2RFFGMUs2VFhESUhLNWRicmUyT245ZFNNSlFjb1pnNmZBb3NTM3JWTDkwQXMxRjNkZWNj?oc=5" target="_blank">Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial</a>  <font color="#6f6f6f">Nature</font>

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System
Naturegeneral

Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1DSjlSV3dzLWl5MUpSZnBpblhUVUJBY3NfZVRuMC1JOERjUmVoNktyUDdHcGttTzNTUEotYTV3Vl92SEhpS3hlWjAzVzk0VEJBQjJCRkRscWNXak1pT0NV?oc=5" target="_blank">Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System</a>  <font color="#6f6f6f">Nature</font>

GLP-1 receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation
Naturegeneral

GLP-1 receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBDZEc1Y0h2d2hfZGJnZU1Fcm9fei1QbzRjaFFPNmFzSFF4SnhuY1ZyWnlfUFNpSmxjMVFsdEc0YngxMHh5a1Rnb0JFVjF3R1duaWtwbTBOaU56RUV4SWY0?oc=5" target="_blank">GLP-1 receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation</a>  <font color="#6f6f6f">Nature</font>

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Frontiersworld

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNZXhsRGY5dUNBVkg2T3Zfa3hwb0U2VUZpX3ZnWmhmaHkyUTl3STAtbGMwZnNuN1Z3VnJhMXlhSTVxX2YyTEhLUlJScl9YZDV4OVJwSkx4UVNWYUpVblJBYVZoZUxpLVFUeTU3OW9pcDFmX291SUpNRU9zSFA5VW9MamxDbUpXRzlSS01pc0lWeWU1d0k?oc=5" target="_blank">Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function</a>  <font color="#6f6f6f">Frontiers</font>

It’s 2026, and We Still Don’t Know Much About Long-Term GLP Use
Medscapegeneral

It’s 2026, and We Still Don’t Know Much About Long-Term GLP Use

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQYW5MYnZqTnJSdVp3eGJvclJXUkpnTi1zRVUzTDVNWmY0NmhhR3BnZkx4d2tjZEtHclhfOVltR0VLOW9uYTZ6Rk5fUk1Bdm9pUVJUZjhzYndzOS1uNFlNbldiRnoxd2l2a3MzMnJnc0IwaUs1cW1PUEJhVmVTODdjbmVqQl8za1V1cjZhOWRDRmI0ZTBGdEd5bzdFV0Zoajg2aloxWDZPMUoxQXpOZVhV?oc=5" target="_blank">It’s 2026, and We Still Don’t Know Much About Long-Term GLP Use</a>  <font color="#6f6f6f">Medscape</font>

2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
Morningstargeneral

2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNQTN2SDVaREtuaEw5WmxTOEF6VEp1UmFzV0M4SE4xdF9uSU9UMm45TUdfYndWcGR5bEFvdF9td3lTUUwtYlhpTEdqSThpNVNQUEFlRnVUNnplUU1IdmtiWExsNjBNQmZYT29wUzZydWVQTkxjbFBjSmFIV29SQlFNeWpUZXJkTWxSdmZTWFpCSTNCaW9HaV9OUlZHMms?oc=5" target="_blank">2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs</a>  <font color="#6f6f6f">Morningstar</font>

Long-Term Effects Of GLP-1 Use: Risks And Benefits
Forbesgeneral

Long-Term Effects Of GLP-1 Use: Risks And Benefits

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9OMkw5UlowdkFJYTVfQXFNeHNCaVMwbi00c28tY1h4dC0tbF9QMF9VcGVkOG1qbXkxSE9NMjB6LXlWR2tJdlBfZm54cFM1OHkzNzFrbHQ0aGs1LUtyNTV5T0dDeXlQMVJQSzl1b1hydlZURHBJ?oc=5" target="_blank">Long-Term Effects Of GLP-1 Use: Risks And Benefits</a>  <font color="#6f6f6f">Forbes</font>

Pulsatile liraglutide on a biased tirzepatide background: a hypothesis
Frontiersworld

Pulsatile liraglutide on a biased tirzepatide background: a hypothesis

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPUzJKNDNyNVczRmd2Y1dLQU05bjV5VjFsTlM5UUxtYVZTU0g3Rnp4TmJuMThLRFl5cDd4MXpucUVIZ2pyejZqOTlzYVFIM1NYdW4xekVUMjlrSnJuYkpsM1N5WTBlMjcwQzREbTJvbGpabFJQTWhQclFSY3g4RDFVVVBhZEFrQ2g3eUFKSlJIZHNxUnl4eFE?oc=5" target="_blank">Pulsatile liraglutide on a biased tirzepatide background: a hypothesis</a>  <font color="#6f6f6f">Frontiers</font>

Revealing the role of increased SK3 expression in sulfonylurea resistance triggered by prolonged exposure
Naturegeneral

Revealing the role of increased SK3 expression in sulfonylurea resistance triggered by prolonged exposure

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1tMUZqV282YmRmdTdOSTctMXd0dGhGcnpzZ29UeHczUUlPQkNTc3VNY1hiTTgzUlpxVWE0Q19QQUVQQXJkZ1ZqeHVtU3ZSWDUxbE9zQXVZVWp0MmN3RG5F?oc=5" target="_blank">Revealing the role of increased SK3 expression in sulfonylurea resistance triggered by prolonged exposure</a>  <font color="#6f6f6f">Nature</font>

Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits
Drug Topicstech

Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPaFVvUUpINWpOMU9ENVdaeDM0SXhTRDRMZHViSDRXQW1RU2NLMng0cmVIODVUcXZaaENXeGdfck9RWDRhMVhpdGw5bjdoQU9tRnZuaUdNZHozdFQ2R2lzRmU4LWFEenFCQmFmSEhXckRPUUpHVVNmNGZRY3JSd3FPREVPWVVES3pFT2FwcTk2YUw?oc=5" target="_blank">Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits</a>  <font color="#6f6f6f">Drug Topics</font>

Ozempic and vision loss: GLP-1 drugs may double risk of eye disease
MedicalNewsTodaygeneral

Ozempic and vision loss: GLP-1 drugs may double risk of eye disease

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxPcFRodWZYb3NndGp4aXJZU25KUGJoaWF6YkZDQXhJNzZSNHNISGdIZUlCOFM5LUZVY3VGTEIxY1RvQU9WNFlLREdzd3V1a2tMVHhnNElzc1JIcGM1TTVhdFZMOGxHVnVoMnNPUTk3UzBOT1lob01EVFRTSXVQY2ZwLVUxb1o1T1ZCX2hEcGthN0J3MFJlMDRWbkpfRGY5Um0xZUNLc2Zabjkzdm9tSm5RdF82Qm1NOHd3N1F2a1JVMDgtQzZoM1VoeDZxd3hKZ3V1REU3ckdOSTFfemc?oc=5" target="_blank">Ozempic and vision loss: GLP-1 drugs may double risk of eye disease</a>  <font color="#6f6f6f">MedicalNewsToday</font>

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
Naturegeneral

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBOX1REejNUT2wwQlo1dGY0X0w1cnB1blg3aXMwVktDVkVrN091emMzdnBDb2d2TGtpQUJrZ2R2cVA2LVpNWElETjJLOTFHcWowUEV2WDA1VW9WbTFWU0ZF?oc=5" target="_blank">Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial</a>  <font color="#6f6f6f">Nature</font>

Targeting GLP-1 receptor trafficking to improve agonist efficacy
Naturegeneral

Targeting GLP-1 receptor trafficking to improve agonist efficacy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9LamI5cjc4MWFpZnc5VHdNaGxYRkhPVldDQ1JhMUt1VVRZYjlwUm5JLW5sbmM1b05NVDNLZlZicEJOMnN3Um5sYUZYYW53dW9obVdvTElaRnhIYkRVOHJj?oc=5" target="_blank">Targeting GLP-1 receptor trafficking to improve agonist efficacy</a>  <font color="#6f6f6f">Nature</font>

GLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration
Healthlinegeneral

GLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNUVJTMzFNZmt2WTRRejBkNU9WamdLby0yQUhPT1dzcl9DMWw2S1Q4T3UzNnZNektvcVlqei15bWNobzNIRkMxbHF5cTgwRmtQS0UtUUU5RFFFQlJNMk5UQ0VHd2t6bk41VmhCR1VXTXUtNlVpLXlrekVnclJ0SVRWZHJnV0ZqNGNLQ1B2ZWltLTAwZw?oc=5" target="_blank">GLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration</a>  <font color="#6f6f6f">Healthline</font>

"Prolonged GLP-1 Exposure" — Live Google News Trends & Headlines